antibodies targeting col2a1 (Proteintech)
Proteintech is a verified supplier 
96
Structured Review
Proteintech
antibodies targeting col2a1
Antibodies Targeting Col2a1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 606 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col2a1/Collagen+Type+II+Antibody/pmc13658529-179-7-10
Average 96 stars, based on 606 article reviews
Antibodies Targeting Col2a1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 606 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col2a1/Collagen+Type+II+Antibody/pmc13658529-179-7-10
Average 96 stars, based on 606 article reviews
antibodies targeting col2a1 - by Bioz Stars,
2026-10
96/100 stars
Images
1) Product Images from "pH-responsive Zn 2+ -coordinated gellan gum/γ-polyglutamic acid hydrogel microspheres as functional biomaterials for intra-articular delivery: physicochemical design, smart release, and chondroprotective performance in osteoarthritis"
Article Title: pH-responsive Zn 2+ -coordinated gellan gum/γ-polyglutamic acid hydrogel microspheres as functional biomaterials for intra-articular delivery: physicochemical design, smart release, and chondroprotective performance in osteoarthritis
Journal: Frontiers in Bioengineering and Biotechnology
doi: 10.3389/fbioe.2026.1924086
Figure Legend Snippet: qPCR primer information.
Techniques Used: Sequencing
Figure Legend Snippet: PGG-Zn@Cur restored matrix metabolic homeostasis in IL-1β-stimulated chondrocytes. (A) Representative immunofluorescence images of COL2A1 in chondrocytes after different treatments. COL2A1 was stained red, and nuclei were counterstained with DAPI. (B) Representative immunofluorescence images of MMP13 in chondrocytes after different treatments. MMP13 was stained green, and nuclei were counterstained with DAPI. (C) Quantitative analysis of relative fluorescence intensity for COL2A1 and MMP13 based on immunofluorescence staining. IL-1β stimulation decreased COL2A1 expression and increased MMP13 accumulation, whereas PGG-Zn@Cur treatment restored COL2A1 fluorescence intensity and suppressed MMP13-positive signals. (D–G) RT-qPCR analysis of cartilage matrix metabolism-related genes, including anabolic markers Col2a1 and Aggrecan, and catabolic markers Mmp13 and Adamts5, in chondrocytes after the indicated treatments. (H) Representative Western blot images of iNOS, COL2A1, MMP13, and ACAN protein expression, together with heatmap-based quantitative analysis of Western blot results across different treatment groups. β-Actin was used as the loading control. ( n = 3, Scale bar: 10 μm *: p < 0.05; **: p < 0.01; ***: p < 0.001; ****: p < 0.0001; ns: no significant).
Techniques Used: Immunofluorescence, Staining, Analysis, Fluorescence, Expressing, Quantitative RT-PCR, Western Blot, Control
Figure Legend Snippet: PGG-Zn@Cur attenuated PI3K-AKT activation and apoptosis-associated responses in IL-1β-stimulated chondrocytes. (A) Schematic workflow of RNA sequencing and subsequent experimental validation. (B) Heatmap of representative differentially expressed genes related to cartilage matrix metabolism, inflammation, apoptosis, and PI3K-AKT-associated signaling. (C) Volcano plot showing differentially expressed genes between the indicated groups, with representative genes related to cartilage homeostasis, apoptosis, and PI3K-AKT signaling labeled. (D) GO enrichment analysis of differentially expressed genes, including biological process, cellular component, and molecular function categories. (E) KEGG pathway enrichment analysis, with the PI3K-AKT signaling pathway highlighted as a candidate pathway. (F) Representative immunofluorescence images of p-PI3K, p-AKT, Cl-Caspase3, and COL2A1 in chondrocytes after different treatments. Nuclei were counterstained with DAPI. (G) Quantitative analysis of p-PI3K, p-AKT, Cl-Caspase3, and COL2A1 fluorescence intensity. (H) Representative Western blot images of PI3K-AKT pathway- and apoptosis-related proteins, including p-PI3K, PI3K, p-AKT, AKT, Cleaved-Caspase3, Caspase3, Bax, and BCL2. β-Actin was used as the loading control. (I) Heatmap-based quantitative analysis of Western blot results, summarizing changes in p-PI3K/PI3K, p-AKT/AKT, Cleaved-Caspase3/Caspase3, Bax/β-Actin, and BCL2/β-Actin across different groups. ( n = 3, Scale bar: 10 μm *: p < 0.05; **: p < 0.01; ***: p < 0.001; ****: p < 0.0001; ns: not significant).
Techniques Used: Activation Assay, RNA Sequencing, Biomarker Discovery, Labeling, Analysis, Immunofluorescence, Fluorescence, Western Blot, Control
Figure Legend Snippet: PGG-Zn@Cur attenuates OA-associated cartilage degeneration and preserves matrix homeostasis in vivo . (A) Representative Safranin O/Fast Green staining images of knee joint cartilage from the Sham, OA, OA+ PGG-Zn, OA+ Cur, and OA+ PGG-Zn@Cur groups. (B) Representative immunofluorescence images of COL2A1 and MMP13 in articular cartilage from different groups. Nuclei were counterstained with DAPI. (C, D) Quantitative analysis of cartilage degeneration using OARSI scores and modified Mankin’s scores. (E) Quantitative analysis of COL2A1 and MMP13 fluorescence intensity in articular cartilage. ( n = 5 mice per group, Scale bar: 50 μm *: p < 0.05; **: p < 0.01; ***: p < 0.001; ****: p < 0.0001; ns: not significant).
Techniques Used: In Vivo, Staining, Immunofluorescence, Analysis, Modification, Fluorescence
Figure Legend Snippet: PGG-Zn@Cur attenuates PI3K-AKT pathway activation and apoptosis-associated cartilage damage in vivo . (A) Representative immunofluorescence images of p-PI3K, p-AKT, and COL2A1 in articular cartilage from the Sham, OA, OA+ PGG-Zn, OA+ Cur, and OA+ PGG-Zn@Cur groups. Nuclei were counterstained with DAPI. (B) Representative TUNEL staining images of articular cartilage from different groups. (C) Quantitative analysis of p-PI3K, p-AKT, and COL2A1 fluorescence intensity in articular cartilage. (D) Quantitative analysis of TUNEL-positive chondrocytes in articular cartilage. ( n = 5 mice per group, Scale bar: 50 μm *: p < 0.05; **: p < 0.01; ***: p < 0.001; ****: p < 0.0001; ns: not significant).
Techniques Used: Activation Assay, In Vivo, Immunofluorescence, TUNEL Assay, Staining, Analysis, Fluorescence
Related Articles
Western Blot:Article Title: Recycling senescent cell lipids for targeted senotherapy. Article Snippet: Nanoparticle modification ICAM-1 monoclonal antibody (R&D Systems, BBA3 or Abcam, ab171123) was modified onto the surface of nanoparticles to achieve different targeting requirements. .. Western blot ICAM1 (ABclonal, A20472, 1: 1000), Na/K-ATPase β1 (Cell Signalling Technology, #44759, 1:1000), Cdkn2a (Proteintech, 10883-1AP, 1:1000), Cdkn1a (Santa Cruz, Sc-6246, 1:150), beta-actin (Boster Biological Technology, BM0627), Aggrecan (ABclonal, A8536, 1:500), Article Title: Recycling senescent cell lipids for targeted senotherapy. Article Snippet: Antibody and drugs Nanoparticle modification ICAM-1 monoclonal antibody (R&D Systems, BBA3 or Abcam, ab171123) was modified onto the surface of nanoparticles to achieve different targeting requirements. .. Western blot ICAM1 (ABclonal, A20472, 1: 1000), Na/K-ATPase β1 (Cell Signalling Technology, #44759, 1:1000), Cdkn2a (Proteintech, 10883-1AP, 1:1000), Cdkn1a (Santa Cruz, Sc-6246, 1:150), beta-actin (Boster Biological Technology, BM0627), Aggrecan (ABclonal, A8536, 1:500), Immunofluorescence:Article Title: Recycling senescent cell lipids for targeted senotherapy. Article Snippet: Nanoparticle modification ICAM-1 monoclonal antibody (R&D Systems, BBA3 or Abcam, ab171123) was modified onto the surface of nanoparticles to achieve different targeting requirements. .. Western blot ICAM1 (ABclonal, A20472, 1: 1000), Na/K-ATPase β1 (Cell Signalling Technology, #44759, 1:1000), Cdkn2a (Proteintech, 10883-1AP, 1:1000), Cdkn1a (Santa Cruz, Sc-6246, 1:150), beta-actin (Boster Biological Technology, BM0627), Aggrecan (ABclonal, A8536, 1:500), Article Title: Recycling senescent cell lipids for targeted senotherapy. Article Snippet: Antibody and drugs Nanoparticle modification ICAM-1 monoclonal antibody (R&D Systems, BBA3 or Abcam, ab171123) was modified onto the surface of nanoparticles to achieve different targeting requirements. .. Western blot ICAM1 (ABclonal, A20472, 1: 1000), Na/K-ATPase β1 (Cell Signalling Technology, #44759, 1:1000), Cdkn2a (Proteintech, 10883-1AP, 1:1000), Cdkn1a (Santa Cruz, Sc-6246, 1:150), beta-actin (Boster Biological Technology, BM0627), Aggrecan (ABclonal, A8536, 1:500), Article Title: An intelligent nanoliposome alleviates disc degeneration and discogenic pain by inhibiting neurovascular ingrowth via a “Soil-conditioning, seed-modulating, and weeds-suppressing” strategy Article Snippet: .. For immunofluorescence (IF) staining, antigen retrieval was conducted using citrate buffer (0.1 M, pH 6.0), followed by blocking in 10 % normal goat serum (Solarbio, Cat. No. SL038) at room temperature for 1 h. Sections were incubated overnight at 4 °C with primary antibodies targeting ACAN (Cat. No. DF7561, Affinity), Flow Cytometry:Article Title: Recycling senescent cell lipids for targeted senotherapy. Article Snippet: Nanoparticle modification ICAM-1 monoclonal antibody (R&D Systems, BBA3 or Abcam, ab171123) was modified onto the surface of nanoparticles to achieve different targeting requirements. .. Western blot ICAM1 (ABclonal, A20472, 1: 1000), Na/K-ATPase β1 (Cell Signalling Technology, #44759, 1:1000), Cdkn2a (Proteintech, 10883-1AP, 1:1000), Cdkn1a (Santa Cruz, Sc-6246, 1:150), beta-actin (Boster Biological Technology, BM0627), Aggrecan (ABclonal, A8536, 1:500), Article Title: Recycling senescent cell lipids for targeted senotherapy. Article Snippet: Antibody and drugs Nanoparticle modification ICAM-1 monoclonal antibody (R&D Systems, BBA3 or Abcam, ab171123) was modified onto the surface of nanoparticles to achieve different targeting requirements. .. Western blot ICAM1 (ABclonal, A20472, 1: 1000), Na/K-ATPase β1 (Cell Signalling Technology, #44759, 1:1000), Cdkn2a (Proteintech, 10883-1AP, 1:1000), Cdkn1a (Santa Cruz, Sc-6246, 1:150), beta-actin (Boster Biological Technology, BM0627), Aggrecan (ABclonal, A8536, 1:500), Incubation:Article Title: Iron toxicity undermines microfracture-induced cartilage regeneration by predisposing a pre-ferroptotic niche Article Snippet: .. The sections were incubated with the primary antibodies overnight at 4 °C, respectively, including Acan (1:500, bs-1223R, Boiss, China), Article Title: KLK8 promotes cartilage degradation and pyroptosis in osteoarthritis by activating the NF-κB and NLRP3 inflammasome pathways. Article Snippet: Cartilage degradation, inflammation, and pyroptosis are key drivers of Osteoarthritis (OA) pathogenesis, contributing to chondrocyte impairment.. However, the therapeutic potential of KLK8, a cartilage-associated protease, remains unexplored in OA.. KLK8 expression was detected in meniscal/ligamentous injury (MLI)induced OA mouse models and human OA cartilage tissues. Article Title: An intelligent nanoliposome alleviates disc degeneration and discogenic pain by inhibiting neurovascular ingrowth via a “Soil-conditioning, seed-modulating, and weeds-suppressing” strategy Article Snippet: .. For immunofluorescence (IF) staining, antigen retrieval was conducted using citrate buffer (0.1 M, pH 6.0), followed by blocking in 10 % normal goat serum (Solarbio, Cat. No. SL038) at room temperature for 1 h. Sections were incubated overnight at 4 °C with primary antibodies targeting ACAN (Cat. No. DF7561, Affinity), other:Article Title: A dual-functional hydrogel integrating adhesive and lubricating interfaces for mitochondrial protection-Driven cartilage regeneration. Article Snippet: Following three gentle PBS washes, intracellular ROS was acquired on a BD LSRFortessa X-20 flow cytometer (excitation 488 nm, emission 525 nm) and quantified in FlowJo to assess oxidative stress across groups. Cytometry:Article Title: Recycling senescent cell lipids for targeted senotherapy. Article Snippet: Antibody and drugs Nanoparticle modification ICAM-1 monoclonal antibody (R&D Systems, BBA3 or Abcam, ab171123) was modified onto the surface of nanoparticles to achieve different targeting requirements. .. Western blot ICAM1 (ABclonal, A20472, 1: 1000), Na/K-ATPase β1 (Cell Signalling Technology, #44759, 1:1000), Cdkn2a (Proteintech, 10883-1AP, 1:1000), Cdkn1a (Santa Cruz, Sc-6246, 1:150), beta-actin (Boster Biological Technology, BM0627), Aggrecan (ABclonal, A8536, 1:500), Tissue:Article Title: Recycling senescent cell lipids for targeted senotherapy. Article Snippet: Antibody and drugs Nanoparticle modification ICAM-1 monoclonal antibody (R&D Systems, BBA3 or Abcam, ab171123) was modified onto the surface of nanoparticles to achieve different targeting requirements. .. Western blot ICAM1 (ABclonal, A20472, 1: 1000), Na/K-ATPase β1 (Cell Signalling Technology, #44759, 1:1000), Cdkn2a (Proteintech, 10883-1AP, 1:1000), Cdkn1a (Santa Cruz, Sc-6246, 1:150), beta-actin (Boster Biological Technology, BM0627), Aggrecan (ABclonal, A8536, 1:500), Electrophoresis:Article Title: KLK8 promotes cartilage degradation and pyroptosis in osteoarthritis by activating the NF-κB and NLRP3 inflammasome pathways. Article Snippet: Cartilage degradation, inflammation, and pyroptosis are key drivers of Osteoarthritis (OA) pathogenesis, contributing to chondrocyte impairment.. However, the therapeutic potential of KLK8, a cartilage-associated protease, remains unexplored in OA.. KLK8 expression was detected in meniscal/ligamentous injury (MLI)induced OA mouse models and human OA cartilage tissues. Membrane:Article Title: KLK8 promotes cartilage degradation and pyroptosis in osteoarthritis by activating the NF-κB and NLRP3 inflammasome pathways. Article Snippet: Cartilage degradation, inflammation, and pyroptosis are key drivers of Osteoarthritis (OA) pathogenesis, contributing to chondrocyte impairment.. However, the therapeutic potential of KLK8, a cartilage-associated protease, remains unexplored in OA.. KLK8 expression was detected in meniscal/ligamentous injury (MLI)induced OA mouse models and human OA cartilage tissues. Binding Assay:Article Title: KLK8 promotes cartilage degradation and pyroptosis in osteoarthritis by activating the NF-κB and NLRP3 inflammasome pathways. Article Snippet: Cartilage degradation, inflammation, and pyroptosis are key drivers of Osteoarthritis (OA) pathogenesis, contributing to chondrocyte impairment.. However, the therapeutic potential of KLK8, a cartilage-associated protease, remains unexplored in OA.. KLK8 expression was detected in meniscal/ligamentous injury (MLI)induced OA mouse models and human OA cartilage tissues. Blocking Assay:Article Title: KLK8 promotes cartilage degradation and pyroptosis in osteoarthritis by activating the NF-κB and NLRP3 inflammasome pathways. Article Snippet: Cartilage degradation, inflammation, and pyroptosis are key drivers of Osteoarthritis (OA) pathogenesis, contributing to chondrocyte impairment.. However, the therapeutic potential of KLK8, a cartilage-associated protease, remains unexplored in OA.. KLK8 expression was detected in meniscal/ligamentous injury (MLI)induced OA mouse models and human OA cartilage tissues. Article Title: An intelligent nanoliposome alleviates disc degeneration and discogenic pain by inhibiting neurovascular ingrowth via a “Soil-conditioning, seed-modulating, and weeds-suppressing” strategy Article Snippet: .. For immunofluorescence (IF) staining, antigen retrieval was conducted using citrate buffer (0.1 M, pH 6.0), followed by blocking in 10 % normal goat serum (Solarbio, Cat. No. SL038) at room temperature for 1 h. Sections were incubated overnight at 4 °C with primary antibodies targeting ACAN (Cat. No. DF7561, Affinity), Staining:Article Title: An intelligent nanoliposome alleviates disc degeneration and discogenic pain by inhibiting neurovascular ingrowth via a “Soil-conditioning, seed-modulating, and weeds-suppressing” strategy Article Snippet: .. For immunofluorescence (IF) staining, antigen retrieval was conducted using citrate buffer (0.1 M, pH 6.0), followed by blocking in 10 % normal goat serum (Solarbio, Cat. No. SL038) at room temperature for 1 h. Sections were incubated overnight at 4 °C with primary antibodies targeting ACAN (Cat. No. DF7561, Affinity), Cell Culture:Article Title: A dual-functional hydrogel integrating adhesive and lubricating interfaces for mitochondrial protection–Driven cartilage regeneration Article Snippet: Following three gentle PBS washes, intracellular ROS was acquired on a BD LSRFortessa X-20 flow cytometer (excitation 488 nm, emission 525 nm) and quantified in FlowJo to assess oxidative stress across groups. .. Rat chondrocytes (P1) were seeded in 24-well plates (5 × 10 4 cells per well) and cultured to ∼70–80% confluence, stimulated with LPS (10 μg mL −1 , 12 h) to induce an inflammatory phenotype, and then treated with hydrogel extracts (Hy, AdHy, AdHy@Pae) for 24 h. Cells were washed three times with PBS, fixed in 4% paraformaldehyde for 15 min, permeabilized with 0.1% Triton X-100 (Aladdin, T434386) for 10 min, and blocked with 5% BSA (Solarbio, SW3015) at room temperature for 1 h. Primary antibodies were applied overnight at 4 °C: |
